Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaxfab Enterprises' Board of Directors met on 29th August 2025 and decided to raise funds through a preferential issue, while deferring the proposal to increase authorised share capital to the next board meeting. A follow-up Board Meeting has been scheduled for Friday, 5th September 2025 to consider both the increase in authorised capital and the fund-raising via preferential issue, subject to shareholder and regulatory approvals. In line with SEBI Insider Trading Regulations, the trading window for the company's securities has been closed from 1st September 2025 to 7th September 2025 for all connected and designated persons.
Shareholders should brace for potential equity dilution, as the company is moving toward a preferential allotment and a possible expansion of authorised capital. The trading window closure restricts insider buying or selling until 8th September 2025, which can reduce short-term trading volume but is a routine compliance step.